Quantitative Parameters Relevant for Diabetic Macular Edema Evaluation by Optical Coherence Tomography Angiography.


Journal

Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208

Informations de publication

Date de publication:
10 Jun 2023
Historique:
received: 25 04 2023
revised: 06 06 2023
accepted: 08 06 2023
medline: 29 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Diabetic macular edema (DME) is one of the main ocular complications of diabetes mellitus (DM) that can lead to important vision loss in diabetic patients. In clinical practice, there are cases of DME with unsatisfying treatment responses, despite adequate therapeutic management. Diabetic macular ischemia (DMI) is one of the causes suggested to be associated with the persistence of fluid accumulation. Optical coherence tomography angiography (OCTA) is a non-invasive imaging modality, able to give in-depth information about retinal vascularization in a 3-dimensional manner. The OCTA devices currently available can provide various OCTA metrics that quantitatively assess the retinal microvasculature. In this paper, we reviewed the results of multiple studies that investigated the changes in OCTA metrics in the setting of DME and their possible contribution to the diagnosis, therapeutic management, follow-up and prognosis of patients with DME. We analyzed and compared relevant studies that investigated OCTA parameters related to changes in macular perfusion in the setting of DME and we evaluated the correlations between DME and several quantitative parameters, such as vessel density (VD), perfusion density (PD), foveal avascular zone (FAZ)-related parameters, as well as complexity indices of retinal vasculature. The results of our research showed that OCTA metrics, evaluated especially at the level of the deep vascular plexus (DVP), are useful instruments that can contribute to the assessment of patients with DME.

Identifiants

pubmed: 37374324
pii: medicina59061120
doi: 10.3390/medicina59061120
pmc: PMC10300947
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

JAMA Ophthalmol. 2017 Apr 01;135(4):306-312
pubmed: 28208170
Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):3065-3072
pubmed: 28622398
Sci Rep. 2021 Dec 3;11(1):23398
pubmed: 34862410
Transl Vis Sci Technol. 2022 Oct 3;11(10):5
pubmed: 36180027
Sci Rep. 2017 Feb 10;7:42201
pubmed: 28186181
Ophthalmology. 2019 Dec;126(12):1675-1684
pubmed: 31358386
Am J Ophthalmol. 2023 Jan;245:164-173
pubmed: 35863493
Ann Transl Med. 2020 Sep;8(18):1205
pubmed: 33241054
Retina. 2015 Nov;35(11):2163-80
pubmed: 26428607
Int J Ophthalmol. 2021 Dec 18;14(12):1888-1894
pubmed: 34926204
Exp Eye Res. 1995 Jul;61(1):1-16
pubmed: 7556462
Ther Adv Ophthalmol. 2020 Aug 27;12:2515841420947931
pubmed: 32923938
Ophthalmol Ther. 2022 Apr;11(2):653-660
pubmed: 35088300
Acta Ophthalmol. 2017 Dec;95(8):e751-e755
pubmed: 28211261
Am J Ophthalmol. 2016 May;165:39-46
pubmed: 26921803
J Diabetes Res. 2016;2016:2156273
pubmed: 27761468
Clin Ophthalmol. 2022 Feb 02;16:247-263
pubmed: 35140455
Cureus. 2018 Jul 30;10(7):e3064
pubmed: 30280060
Prog Retin Eye Res. 2018 Mar;63:20-68
pubmed: 29126927
Retina. 2016 Oct;36(10):1823-42
pubmed: 27328171
Eye Vis (Lond). 2022 Apr 5;9(1):14
pubmed: 35382892
J Biomed Opt. 2016 Jun 1;21(6):66008
pubmed: 27286188
Int J Mol Sci. 2017 Jun 02;18(6):
pubmed: 28574436
Cells. 2022 Oct 25;11(21):
pubmed: 36359761
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT362-70
pubmed: 27409494
Graefes Arch Clin Exp Ophthalmol. 2019 Apr;257(4):689-697
pubmed: 30824996
Ophthalmol Sci. 2022 Jun;2(2):
pubmed: 35647573
J Diabetes Res. 2022 Jan 19;2022:8435603
pubmed: 35097131
World J Diabetes. 2011 Jun 15;2(6):98-104
pubmed: 21860693
Transl Vis Sci Technol. 2022 Sep 1;11(9):7
pubmed: 36107113
Ophthalmology. 2021 Nov;128(11):1580-1591
pubmed: 33940045
Ophthalmology. 2017 Feb;124(2):235-244
pubmed: 27887743
Retina. 2016 Dec;36 Suppl 1:S102-S110
pubmed: 28005668
Pak J Med Sci. 2016 Mar-Apr;32(2):505-10
pubmed: 27182271
Sci Rep. 2018 Aug 27;8(1):12897
pubmed: 30150636
Retina. 2020 Feb;40(2):312-321
pubmed: 31972802
Annu Rev Vis Sci. 2021 Sep 15;7:129-153
pubmed: 34171198
Ophthalmology. 2016 Nov;123(11):2368-2375
pubmed: 27613201
Ophthalmic Res. 2021;64(6):871-887
pubmed: 34348330
Front Pharmacol. 2022 Apr 06;13:832448
pubmed: 35462889
Eye (Lond). 2020 Mar;34(3):544-552
pubmed: 31406356
PLoS One. 2017 Sep 21;12(9):e0184948
pubmed: 28934255
Br J Ophthalmol. 2020 Feb;104(2):162-166
pubmed: 31036586
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT211-23
pubmed: 27409475
Int Ophthalmol. 2019 Aug;39(8):1845-1859
pubmed: 30194547
Retina. 2021 Sep 1;41(9):1799-1808
pubmed: 33587426
Acta Diabetol. 2020 Mar;57(3):287-296
pubmed: 31541333
JAMA Ophthalmol. 2015 Jan;133(1):45-50
pubmed: 25317632

Auteurs

Alina-Simona Lazăr (AS)

Doctoral School, "Carol Davila" University of Medicine and Pharmacy, Strada Dionisie Lupu No. 37, 020021 Bucharest, Romania.
Clinical Department of Ophthalmology, "Prof. Dr. Agrippa Ionescu" Emergency Hospital, Strada Ion Mincu No. 7, 011356 Bucharest, Romania.

Horia T Stanca (HT)

Doctoral School, "Carol Davila" University of Medicine and Pharmacy, Strada Dionisie Lupu No. 37, 020021 Bucharest, Romania.
Clinical Department of Ophthalmology, "Prof. Dr. Agrippa Ionescu" Emergency Hospital, Strada Ion Mincu No. 7, 011356 Bucharest, Romania.

Bogdana Tăbăcaru (B)

Clinical Department of Ophthalmology, "Prof. Dr. Agrippa Ionescu" Emergency Hospital, Strada Ion Mincu No. 7, 011356 Bucharest, Romania.

Ciprian Danielescu (C)

Department of Ophthalmology, Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa", Strada Universitatii No. 16, 700115 Iasi, Romania.

Mihnea Munteanu (M)

Department of Ophthalmology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Simona Stanca (S)

Clinical Department of Pediatrics, University of Medicine and Pharmacy "Carol Davila", Strada Dionisie Lupu No. 37, 020021 Bucharest, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH